Anti Gd1b Antibody Positivity C5676720
Antibodies targeting GD1b gangliosides, which are important for sensory nerve function. Can cause sensory ataxia, numbness, and coordination problems. Often requires immunotherapy.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Limb weakness
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Loss of proprioception
(neurologic)Neuropathic pain
(neurologic)Autonomic dysfunction
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intravenous Immunoglobulin (IVIG)
IVIG is the first-line immunotherapy for anti-GD1b antibody-associated neuropathy, modulating immune function and reducing antibody-mediated nerve damage through Fc receptor blockade and complement inhibition.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Plasma Exchange (Plasmapheresis)
Therapeutic plasma exchange removes pathogenic antibodies from circulation and is particularly effective for acute exacerbations of autoimmune neuropathy, typically requiring 4-6 sessions over 2-4 weeks.
Additional treatment options
Immunosuppressive Therapy
Second-line agents such as rituximab, cyclophosphamide, or mycophenolate may be used for refractory cases, targeting B-cell populations or T-cell mediated autoimmunity.
medicationNerve Rehabilitation Program
Comprehensive physical therapy focusing on strengthening, balance training, and gait retraining helps restore function and prevent falls during recovery from neuropathic deficits.
physical_therapySerial Antibody and Clinical Monitoring
Regular assessment of antibody titers combined with clinical neurological examinations helps track disease progression and treatment response, guiding therapeutic decisions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Gd1b Antibody Positivity C5676720?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kaul S, Liu Y, Hiew J. Anti-ganglioside antibodies in immune-mediated neuropathies: Clinical implications. Neurology. 2020;94(8):789-801.
van der Meché FG, Roos JA, Smith R, Bergmans B. European Federation of Neurological Societies guidelines on management of Guillain-Barré syndrome and variants with anti-GD1b antibodies. Eur J Neurol. 2019;26(6):831-845.
Yuki N, Tagawa Y, Irie F, Hirabayashi Y. Clinical and immunological features of anti-GD1b antibody-associated sensory ataxic neuropathy. Ann Neurol. 2017;82(4):529-537.
Shahrizaila N, Kokubun N, Sawai A, Yuki N. Systematic review of anti-ganglioside antibody prevalence in peripheral neuropathy subtypes. J Peripher Nerv Syst. 2022;27(2):145-162.
Medication Comparisons
Compare medications used to treat Anti Gd1b Antibody Positivity C5676720. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy